$DNA
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Jason Kelly
CEO
834
Employees
$11.47
Current Price
$504.93M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $36,045.00 | 2,403 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $71,450.00 | 7,403 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 3 | $73,752.41 | 7,733 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $79,695.47 | 8,485 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Coen Steven P. Chief Financial Officer | Sale | 2,403 | $15.00 | $36,045.00 | View Details |
| Sep 15, 2026 | HENRY CHRISTIAN O Director | Sale | 5,000 | $7.08 | $35,405.00 | View Details |
| Aug 24, 2026 | Coen Steven P. Chief Financial Officer | Sale | 330 | $6.98 | $2,302.41 | View Details |
| Jul 17, 2026 | Coen Steven P. Chief Financial Officer | Sale | 752 | $7.90 | $5,943.06 | View Details |
15 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.58
ActualN/A
Revenue
Estimated$21.57M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.